Works matching IS 15228517 AND DT 2024 AND VI 26 AND IP 4
Results: 22
Targeted therapy done right: Direct sonic hedgehog inhibition for sonic hedgehog medulloblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 623, doi. 10.1093/neuonc/noae018
- By:
- Publication type:
- Article
A paradigm shift in how we treat pediatric low-grade glioma—Targeting the molecular drivers.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 593, doi. 10.1093/neuonc/noae008
- By:
- Publication type:
- Article
Forthcoming Meetings.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 781, doi. 10.1093/neuonc/noae023
- Publication type:
- Article
Radiotherapy dose escalation for high-risk meningiomas after subtotal resection.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 713, doi. 10.1093/neuonc/noad262
- By:
- Publication type:
- Article
Correction to: RADT-49. A SYSTEMATIC REVIEW AND META-ANALYSIS OF HIPPOCAMPAL AVOIDANCE IN WHOLE BRAIN RADIOTHERAPY AND PROPHYLACTIC CRANIAL IRRADIATION.
- Published in:
- 2024
- Publication type:
- Correction Notice
Correction to: TSPO deficiency induces mitochondrial dysfunction, leading to hypoxia, angiogenesis, and a growth-promoting metabolic shift toward glycolysis in glioblastoma.
- Published in:
- 2024
- Publication type:
- Correction Notice
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 701, doi. 10.1093/neuonc/noad244
- By:
- Publication type:
- Article
Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 596, doi. 10.1093/neuonc/noad242
- By:
- Publication type:
- Article
Correction to: Lessons learned from phase 3 trials of immunotherapy for glioblastoma: Time for longitudinal sampling?
- Published in:
- 2024
- Publication type:
- Correction Notice
The impact of COVID-19 on 2020 monthly incidence trends of primary brain and other CNS tumors.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 764, doi. 10.1093/neuonc/noad235
- By:
- Publication type:
- Article
Cholesterol homeostasis confers glioma malignancy triggered by hnRNPA2B1-dependent regulation of SREBP2 and LDLR.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 684, doi. 10.1093/neuonc/noad233
- By:
- Publication type:
- Article
Metabolic modulation of histone acetylation mediated by HMGCL activates the FOXM1/β-catenin pathway in glioblastoma.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 653, doi. 10.1093/neuonc/noad232
- By:
- Publication type:
- Article
Whole tumor analysis reveals early origin of the TERT promoter mutation and intercellular heterogeneity in TERT expression.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 640, doi. 10.1093/neuonc/noad231
- By:
- Publication type:
- Article
Association of county-level socioeconomic status with meningioma incidence and outcomes.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 749, doi. 10.1093/neuonc/noad223
- By:
- Publication type:
- Article
Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 735, doi. 10.1093/neuonc/noad222
- By:
- Publication type:
- Article
Stereotactic radiosurgery for nonfunctioning pituitary tumor: A multicenter study of new pituitary hormone deficiency.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 715, doi. 10.1093/neuonc/noad215
- By:
- Publication type:
- Article
Survival, neurocognitive function, and health-related quality of life outcomes after rituximab—methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 724, doi. 10.1093/neuonc/noad224
- By:
- Publication type:
- Article
Cognitive functioning in untreated glioma patients: The limited predictive value of clinical variables.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 670, doi. 10.1093/neuonc/noad221
- By:
- Publication type:
- Article
Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 625, doi. 10.1093/neuonc/noad210
- By:
- Publication type:
- Article
Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 4, p. 609, doi. 10.1093/neuonc/noad191
- By:
- Publication type:
- Article
Erratum to: METB-13. A SINGLE-CELL GENETIC IN VIVO LINEAGE-TRACING PLATFORM FOR MEDULLOBLASTOMA.
- Published in:
- 2024
- Publication type:
- Correction Notice
Retraction of: PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors.
- Published in:
- 2024
- Publication type:
- Correction Notice